Literature DB >> 26897146

Blood Pressure-to-Height Ratio as a Screening Tool for Hypertension in Children.

Asif Ahmed1, Syed Wajid Ali, Shariq Massodi, Mushtaq Ahmad Bhat.   

Abstract

OBJECTIVE: To test whether blood pressure-to-height ratio (BPHR) can be used to screen for hypertension in children.
METHODS: Data regarding blood pressure and other variables was recorded for 2702 school children between the ages of 10-16 years as a part of a nutritional survey.
RESULTS: The optimal thresholds for defining hypertension in boys were 0.76 for systolic BPHR and 0.50 for diastolic BPHR; the respective threshold in girls were 0.80 and 0.52.
CONCLUSION: BPHR can be used as an effective screening test for diagnosing both hypertension and prehypertension in children aged 10-16 years.

Entities:  

Mesh:

Year:  2016        PMID: 26897146     DOI: 10.1007/s13312-016-0808-1

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  4 in total

1.  Performance of modified blood pressure-to-height ratio for identifying hypertension in Chinese and American children.

Authors:  Yuanyuan Zhang; Chuanwei Ma; Lili Yang; Pascal Bovet; Bo Xi
Journal:  J Hum Hypertens       Date:  2018-04-06       Impact factor: 3.012

2.  Blood pressure-to-height ratio as a screening indicator of elevated blood pressure among children and adolescents in Chongqing, China.

Authors:  L Y Wang; Q Liu; X T Cheng; J J Jiang; H Wang
Journal:  J Hum Hypertens       Date:  2016-12-29       Impact factor: 3.012

3.  Using blood pressure height index to define hypertension among secondary school adolescents in southwestern Uganda.

Authors:  Godfrey Katamba; David Collins Agaba; Richard Migisha; Agnes Namaganda; Rosemary Namayanja; Eleanor Turyakira
Journal:  J Hum Hypertens       Date:  2019-12-02       Impact factor: 3.012

4.  Performance of modified blood pressure-to-height ratio for diagnosis of hypertension in children: The CASPIAN-V study.

Authors:  Maryam Yazdi; Farahnak Assadi; Seyed S Daniali; Ramin Heshmat; Mehryar Mehrkash; Mohammad E Motlagh; Mostafa Qorbani; Roya Kelishadi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-15       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.